You have 9 free searches left this month | for more free features.

ABT-530

Showing 1 - 25 of 393

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

Completed
  • Chronic Hepatitis C Virus (HCV) Infection
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus Trial (ABT-493, ABT-530, ribavirin (RBV))

Completed
  • Chronic Hepatitis C
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

Completed
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, OBV/PTV/r)

Completed
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Hepatitis C Virus Trial (ABT-493/ABT-530)

Completed
  • Hepatitis C Virus
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

Completed
  • Hepatitis C Virus Infection
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

Completed
  • Hepatitis C Virus Infection
  • +3 more
  • ABT-493 coformulated with ABT-530
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, HCV, Hepatitis C Virus Trial (glecaprevir/pibrentasvir)

Completed
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

Completed
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/pibrentasvir adult formulation, Glecaprevir/pibrentasvir pediatric

Completed
  • Hepatitis C Virus (HCV)
  • Glecaprevir/pibrentasvir adult formulation
  • Glecaprevir/pibrentasvir pediatric formulation
  • San Francisco, California
  • +37 more
Sep 19, 2022

Hepatitis C Trial in Worldwide (ABT-493, ABT-530)

Completed
  • Hepatitis C
  • Dothan, Alabama
  • +41 more
Aug 31, 2020

Hepatitis C Virus Infection Trial in Ljubljana (glecaprevir, pibrentasvir)

Approved for marketing
  • Hepatitis C Virus Infection
  • Ljubljana, Slovenia
    Univ Medical Ctr Ljubljana /ID# 161419
Jan 14, 2020

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir)

Completed
  • Hepatitis C Virus (HCV)
  • San Diego, California
  • +24 more
Jul 14, 2021

Hepatitis C Virus (HCV) Trial in China, Korea, Republic of (Glecaprevir/Pibrentasvir)

Completed
  • Hepatitis C Virus (HCV)
  • Beijing, Beijing, China
  • +33 more
Nov 4, 2019

Hepatitis C Virus (HCV) Trial in Worldwide (Glecaprevir/Pibrentasvir (GLE/PIB))

Recruiting
  • Hepatitis C Virus (HCV)
  • Glecaprevir/Pibrentasvir (GLE/PIB)
  • Chandler, Arizona
  • +62 more
Aug 8, 2022

Hepatitis C Virus (HCV) Trial in Brazil (Glecaprevir/Pibrentasvir)

Completed
  • Hepatitis C Virus (HCV)
  • Vitoria, Espirito Santo, Brazil
  • +13 more
Mar 4, 2020

Rheumatoid Arthritis (RA) Trial in Worldwide (Elsubrutinib, Upadacitinib, Placebo for elsubrutinib)

Terminated
  • Rheumatoid Arthritis (RA)
  • Woluwe-Saint-Lambert, Bruxelles-Capitale, Belgium
  • +29 more
Aug 18, 2021

Ulcerative Colitis (UC) Trial in Worldwide (Upadacitinib (ABT-494), Placebo)

Active, not recruiting
  • Ulcerative Colitis (UC)
  • Upadacitinib (ABT-494)
  • Placebo
  • Mobile, Alabama
  • +490 more
Jan 18, 2022

Ulcerative Colitis (UC) Trial in Worldwide (Placebo, Upadacitinib)

Completed
  • Ulcerative Colitis (UC)
  • Mobile, Alabama
  • +378 more
Feb 17, 2022

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Birmingham, Alabama
    A. Brent Carter
Aug 3, 2023